Product Information

AMITRIPTYLINE HCL 150 MG TAB is a generic product labeled by Accord Healthcare Inc., priced at $0.2921 per EA under NDC 16729017601. Its NADAC has been published 589 times since Feb 11, 2015.

The High Outlier badge above means this manufacturer's average price in the AMITRIPTYLINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

AMITRIPTYLINE HCL 150 MG TAB

AMITRIPTYLINE HYDROCHLORIDE
$0.2921per EA
High Outlier

Strength

150 mg/1

NDC

16729017601

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

5/20/2026

Active Ingredients

AMITRIPTYLINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202446

On Market Since

12/26/2014

Pharmacological Classes

Price Statistics

The NADAC for AMITRIPTYLINE HCL 150 MG TAB has been published 589 times since Feb 11, 2015, and over the history we have for it it has declined 82.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2921 per EA
All-time high$1.6689 (Feb 11, 2015)
All-time low$0.1749 (Dec 21, 2022)
52-week high$0.2970
52-week low$0.1953
Median price$0.7540
Average price$0.8298
Largest weekly change+55.6% (Mar 22, 2023)
Weeks tracked589
Tracking sinceFeb 11, 2015

Price History

1W

0.0%

1M

0.0%

3M

+2.8%

6M

+3.4%

1Y

+49.6%

3Y

+3.7%

5Y

-54.3%

All

-82.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the AMITRIPTYLINE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of AMITRIPTYLINE HCL 150 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 150 MG TAB, manufactured by Accord Healthcare Inc., is $0.2921 per EA (NDC 16729017601), effective May 20, 2026.

How has the price of AMITRIPTYLINE HCL 150 MG TAB changed over time?

Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has declined 82.5%. It has been tracked across 589 weekly CMS publications since Feb 11, 2015.

What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 150 MG TAB?

Since Feb 11, 2015, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has ranged from a low of $0.1749 (Dec 21, 2022) to a high of $1.6689 (Feb 11, 2015), with a median of $0.7540 per EA.

Are there cheaper alternatives to AMITRIPTYLINE HCL 150 MG TAB?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMITRIPTYLINE HCL 150 MG TAB, so no direct lower-cost alternative is listed.

Who manufactures AMITRIPTYLINE HCL 150 MG TAB?

AMITRIPTYLINE HCL 150 MG TAB (NDC 16729017601) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.